期刊文献+

早期糖尿病大鼠肾组织尾加压素Ⅱ表达的实验研究

Experimental study on expression of urotensin Ⅱ in renal tissue in STZ-induced early rats with diabetes
下载PDF
导出
摘要 目的:探讨早期糖尿病大鼠肾组织中尾加压素Ⅱ(urotensin Ⅱ,UⅡ)的表达及其意义。方法:用链脲佐菌素(STZ)诱导糖尿病大鼠模型,将实验动物分为正常对照组(C组)、糖尿病组(D组)和胰岛素干预组(Y组)。5周后收集肾组织,观察各组肾脏病理情况及UⅡ在肾组织中的表达。结果:处理5周后,与C、Y组比较,D组肾小球肥大、肾小球表面积显著增大,小管扩张,上皮细胞肿胀;D组肾小管上皮细胞UⅡ表达明显升高(与C组比较,P<0.05);Y组肾小管上皮细胞UⅡ表达有不同程度的下降(与D组比较,P<0.05)。结论:STZ诱导的早期糖尿病大鼠肾小管上皮细胞UⅡ表达明显上调;应用胰岛素严格控制血糖可部分下调肾组织UⅡ的表达。UⅡ在STZ诱导的早期糖尿病大鼠肾脏病变的发展过程中可能起一定作用。 Objective: To explore expression of urotensin Ⅱ in renal tissue in STZ-rats with diabetes and its significance. Methods: Diabetic rats were induced by streptozocin(STZ), the experimental rats were randomly divided into three groups: normal control group(group C), diabetic rats(group D) and diabetic rats treated by insulin(group Y). 5 weeks later, the kidney specimens in different group were randomly collected and fixed in formalin and embedded with paraffin. The expression level and distribution of urotensin Ⅱ were evaluated with immunohistochemistry technique. Results: After treatment of 5 weeks, urotensin Ⅱ levels in renal tubule epithelial cells in group D increased remarkably compared with those in group C(P0.05),while UⅡ levels renal glomerulus endothelial cells in group D didn′t increase markedly.In comparison with group D,urotensinⅡ levels were significantly reduced in group Y (P0.05). Conclusion: The expression of UⅡ in renal tubule epithelial cells upregulated markedly in STZ-rats with diabetes;rigid controls of blood glucose by insulin can partly downregulate the expression of UⅡin renal tissue.UrotensinⅡmight play a role in the development of renal pathological changes in STZ-rats with diabetes.
出处 《中国当代医药》 2010年第9期19-21,共3页 China Modern Medicine
关键词 尾加压素Ⅱ 糖尿病肾病 免疫组织化学 大鼠 Urotensin Ⅱ Diabetic nephropathy Immunohistochemistry Rats
  • 相关文献

参考文献7

  • 1Gonlon JM,Yano K,Waugh D,et al.Distribution and molecular forms of urotensin Ⅱ and its role in cardiovascular regulation invertebrates[J].J Exp Zool,1996,275(2):226-238.
  • 2Ames RS,Sarau HM,Chambers JK,et al.Human urotnesin Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GRP14 [J].Nature, 1999,401 (6750):282-286.
  • 3Langham RG,Kelly DJ,Gow RM,et al.Increased expression of urotensin Ⅱ and urotensin Ⅱ receptor in human diabetic nephropathy [J].Am J Kidney Dis,2004,44(5):826-831.
  • 4Tian L,Li C,Qi J,et al.Diabetes-induced upregulation of urotensin Ⅱ and its receptor plays an important role in TGF-beta1-mediated renal fibrosis and dysfunction[J].Am J Physiol Endocrinol Metab,2008,295(5): 1234-1242.
  • 5王丹,李才,李相军,齐玲,尹俐,高海成.尾加压素Ⅱ对体外培养大鼠肾成纤维细胞的促增殖作用[J].中国老年学杂志,2009,29(12):1457-1459. 被引量:1
  • 6Zhang AY,Chen YF,Zhang DX,et al.Urotensin Ⅱ is a nitric oxidedependent vasodilator and natriuretic peptide in the rat kidney[J].Am J Physiol Renal Physiol,2003,285(4):792-798.
  • 7Behm DJ,McAtee JJ,Dodson JW,et al.Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues[J]. Br J Pharmacol,2008,155 (3):374-386.

二级参考文献9

  • 1Ames RS,Saran HM, Chambers JK,et al. Human urotensin Ⅱ is a potent vasocontrictor and agonist for the orphan receptor GPR14 [ J]. Nature, 1999 ;401 ( 6750 ) : 282-6.
  • 2Langham RG, Kelly D J, Gow RM, et al. Increased expression of urotensin Ⅱ and urotensin Ⅱ receptor in human diabetic nephropathy [ J ]. Am J Kidney Dis,2004;44(5 ) :826-31.
  • 3Rodemann HP, Muller GA. Abnormal growth and clonal proliferation of fibroblasts derived from kidneys with interstitial fibrosis[ J]. J Exp Biol Med, 1990 ; 195 ( 1 ) :57-63.
  • 4Takahashi K, Totsune K, Murakami O, et al. Expression of urotensin Ⅱ and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin Ⅱ [ J ]. Peptides,2003 ;24 ( 2 ) :301-6.
  • 5Tzanidis A, Hannan RD, Thomas WG, et al. Direct action of urotensin Ⅱ on the heart:implications for cardic fibrosis and hypertrophy[ J]. Circres, 2003 ;93:246-53.
  • 6Matsushita M, Shichiri M, Imai T,et al. Co-expression of urotensin Ⅱ and its receptor(GPR14) in human cardiovascular and renal tissues [ J]. J Hypertens,2001 ;19(12) :2185-90.
  • 7Eddy AA. Molecular insights into renal interstitial fibrosis[ J]. J Am Soc Nephrol, 1996 ;7 ( 12 ) :2495-508.
  • 8张勇刚,魏睿宏,李玉光,庞永正,唐朝枢.尾加压素Ⅱ促进肾系膜细胞增殖的细胞内机制研究[J].汕头大学医学院学报,2007,20(3):132-134. 被引量:9
  • 9张勇刚,陈亚红,马春艳,齐永芬,庞永正,杨军,张肇康,唐朝枢.尾加压素Ⅱ的促丝裂作用[J].中国动脉硬化杂志,2001,9(1):14-16. 被引量:61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部